Stock getting pummeled today!!

Discussion in 'Esperion' started by anonymous, Apr 8, 2024 at 1:52 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    We’ve really only just begun this fight. So much positive press coming out of the ACC, this will undoubtedly resolved in a huge uptake of formulary acceptance over the next six months as sales continued to ramp overseas, operational cost go down. CLEARLY there is an unmute need out there that is being fulfilled
     

  2. anonymous

    anonymous Guest

    Last week it was all the Big Pharma Companies buying Esperion.

    This week it is this nonsense from Twinkle Toes.
     
  3. anonymous

    anonymous Guest

    And we’re back under $2. What’s going on here?
     
  4. anonymous

    anonymous Guest

    Wrong again Anthony!! This is a failure of epic proportions. ACC meeting was about as exciting as watching your car go through a carwash. Very weak standing in the market. We're doomed.
     
  5. anonymous

    anonymous Guest

    XBI and ESPR both down again, high tech biosciences has gotten creamed here lately, really makes for an interesting buy point to add to position. Love the opportunity that exists as we move forward and see the future unfold. This is as close to gold as you can get.
     
  6. anonymous

    anonymous Guest

    Your full of it. Your completely dishonest and a charlatan. You should e ashamed of yourself.
     
  7. Hungry Jack

    Hungry Jack Guest

    These high interest rates are killing high-tech bio science. Once we get this under control all bets are off. This one is heading way higher because the fundamentals couldn’t be stronger. The hunger for return will prevail.
     
  8. anonymous

    anonymous Guest

    Sure Anthony. This stock is weak. Since the ACC Esperion has been on a downturn spiral. What a mess.
     
  9. anonymous

    anonymous Guest

    The facts are: Esperion is burning through $$ Millions every month, since releasing BA.
    This continues to increase losses that need to be accounted for.
    If BA hasn't made it by now...
    Well, last one out lock the door.
     
  10. anonymous

    anonymous Guest

    Wow look at that. Under $2…again. I keep waiting for this wave to hit that some yayhoo keeps promising. But all I get are docs telling me they’re not writing it because it’s a PITA to get covered. I literally got laughed at this week during a lunch by 2 doctors. Mortifying. I’m new to pharma and all but this can’t be normal
     
  11. anonymous

    anonymous Guest

    That’s because no one gives a shit about the data. They only care about the financials. Hence the stock price. Expect layoffs within a year if they’re not able to show the ability to get their financials in order
     
  12. anonymous

    anonymous Guest

    ESPR is 2 Buck, Chuck.
     
  13. anonymous

    anonymous Guest

    Trader Karen